Gunnar Casserstedt
Vorsitzender bei KD Incentive AB
Profil
Gunnar Casserstedt is currently the Chairman at KD Incentive AB.
Previously, he was the Deputy Chief Executive Officer & Executive VP at Karolinska Development AB, Chairman at KCIF Fund Management AB, Director at Neurotherapeutics AB and Modus Therapeutics Holding AB, and Chief Financial Officer at Sopherion Therapeutics LLC.
He also served as the Chief Financial Officer at Karolinska Development AB (Private Equity) from 2006 to 2012 and as the Vice President-Finance, Research & Development at Pharmacia, Inc.
Aktive Positionen von Gunnar Casserstedt
Unternehmen | Position | Beginn |
---|---|---|
KD Incentive AB | Vorsitzender | - |
Ehemalige bekannte Positionen von Gunnar Casserstedt
Unternehmen | Position | Ende |
---|---|---|
Neurotherapeutics AB
Neurotherapeutics AB Miscellaneous Commercial ServicesCommercial Services Neurotherapeutics AB researches and develops pharmaceutical products. It identifies and delivers stem cell-based therapies for Parkinson's disease. The company was founded in 2003 by Ernest Arenas and is headquartered in Stockholm, Sweden. | Direktor/Vorstandsmitglied | 19.01.2012 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Finanzdirektor/CFO | 01.01.2012 |
MODUS THERAPEUTICS HOLDING AB | Direktor/Vorstandsmitglied | - |
KCIF Fund Management AB | Vorsitzender | - |
Sopherion Therapeutics LLC
Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Finanzdirektor/CFO | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
KAROLINSKA DEVELOPMENT AB | Finance |
MODUS THERAPEUTICS HOLDING AB | Health Technology |
Private Unternehmen | 6 |
---|---|
Sopherion Therapeutics LLC
Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Health Technology |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Finance |
Pharmacia, Inc. | |
Neurotherapeutics AB
Neurotherapeutics AB Miscellaneous Commercial ServicesCommercial Services Neurotherapeutics AB researches and develops pharmaceutical products. It identifies and delivers stem cell-based therapies for Parkinson's disease. The company was founded in 2003 by Ernest Arenas and is headquartered in Stockholm, Sweden. | Commercial Services |
KCIF Fund Management AB | |
KD Incentive AB |